{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:35:49Z","timestamp":1787243749831,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T00:00:00Z","timestamp":1427155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s13277-015-3329-y","type":"journal-article","created":{"date-parts":[[2015,3,23]],"date-time":"2015-03-23T00:45:55Z","timestamp":1427071555000},"page":"6409-6416","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Radical surgery may be not an optimal treatment approach for pulmonary MALT lymphoma"],"prefix":"10.1007","volume":"36","author":[{"given":"Liang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-jun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-qiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong-yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,24]]},"reference":[{"key":"3329_CR1","doi-asserted-by":"crossref","unstructured":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. The non-Hodgkin\u2019s Lymphoma Classification Project. Blood 1997;89:3909\u20133918.","DOI":"10.1182\/blood.V89.11.3909"},{"key":"3329_CR2","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/0016-5085(92)91723-H","volume":"102","author":"T Radaszkiewicz","year":"1992","unstructured":"Radaszkiewicz T, Dragosics B, Bauer P. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology. 1992;102:1628\u201338.","journal-title":"Gastroenterology"},{"key":"3329_CR3","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V95.3.802.003k19_802_806","volume":"95","author":"C Thieblemont","year":"2000","unstructured":"Thieblemont C, Berger F, Dumontet C, Moullet I, Bouafia F, Felman P, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood. 2000;95:802\u20136.","journal-title":"Blood"},{"key":"3329_CR4","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1002\/1097-0142(19840601)53:11<2515::AID-CNCR2820531125>3.0.CO;2-C","volume":"53","author":"P Isaacson","year":"1984","unstructured":"Isaacson P, Wright DH. Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer. 1984;53:2515\u201324.","journal-title":"Cancer"},{"key":"3329_CR5","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1182\/blood-2005-09-3679","volume":"107","author":"F Suarez","year":"2006","unstructured":"Suarez F, Lortholary O, Hermine O, Lecuit M. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood. 2006;107:3034\u201344.","journal-title":"Blood"},{"key":"3329_CR6","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1182\/blood.V90.2.766","volume":"90","author":"B Royer","year":"1997","unstructured":"Royer B, Cazals-Hatem D, Sibilia J, Agbalika F, Cayuela JM, Soussi T, et al. Lymphomas in patients with Sjogren\u2019s syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood. 1997;90:766\u201375.","journal-title":"Blood"},{"key":"3329_CR7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0140-6736(93)91409-F","volume":"342","author":"AC Wotherspoon","year":"1993","unstructured":"Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993;342:575\u20137.","journal-title":"Lancet"},{"key":"3329_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000028109","volume":"68","author":"T Tschernig","year":"2000","unstructured":"Tschernig T, Pabst R. Bronchus-associated lymphoid tissue (BALT) is not present in the normal adult lung but in different diseases. Pathobiol: J Immunopathol Mol Cell Biol. 2000;68:1\u20138.","journal-title":"Pathobiol: J Immunopathol Mol Cell Biol"},{"key":"3329_CR9","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood.V87.4.1255.bloodjournal8741255","volume":"87","author":"A Savio","year":"1996","unstructured":"Savio A, Franzin G, Wotherspoon AC, Zamboni G, Negrini R, Buffoli F, et al. Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: histology, polymerase chain reaction, or both? Blood. 1996;87:1255\u201360.","journal-title":"Blood"},{"key":"3329_CR10","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1080\/10428190802064933","volume":"49","author":"A Stefanovic","year":"2008","unstructured":"Stefanovic A, Morgensztern D, Fong T, Lossos IS. Pulmonary marginal zone lymphoma: a single centre experience and review of the SEER database. Leuk Lymphoma. 2008;49:1311\u201320.","journal-title":"Leuk Lymphoma"},{"key":"3329_CR11","first-page":"3633","volume":"27","author":"M Troch","year":"2007","unstructured":"Troch M, Streubel B, Petkov V, Turetschek K, Chott A, Raderer M. Does MALT lymphoma of the lung require immediate treatment? An analysis of 11 untreated cases with long-term follow-up. Anticancer Res. 2007;27:3633\u20137.","journal-title":"Anticancer Res"},{"key":"3329_CR12","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ajh.20874","volume":"82","author":"SY Oh","year":"2007","unstructured":"Oh SY, Ryoo BY, Kim WS, Park YH, Kim K, Kim HJ, et al. Nongastric marginal zone B-cell lymphoma: analysis of 247 cases. Am J Hematol. 2007;82:446\u201352.","journal-title":"Am J Hematol"},{"key":"3329_CR13","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/jjco\/hyh095","volume":"34","author":"JH Kim","year":"2004","unstructured":"Kim JH, Lee SH, Park J, Kim HY, Lee SI, Park JO, et al. Primary pulmonary non-Hodgkin\u2019s lymphoma. Jpn J Clin Oncol. 2004;34:510\u20134.","journal-title":"Jpn J Clin Oncol"},{"key":"3329_CR14","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/sj.bjc.6603981","volume":"97","author":"E Chanudet","year":"2007","unstructured":"Chanudet E, Adam P, Nicholson AG, Wotherspoon AC, Ranaldi R, Goteri G, et al. Chlamydiae and Mycoplasma infections in pulmonary MALT lymphoma. Br J Cancer. 2007;97:949\u201351.","journal-title":"Br J Cancer"},{"key":"3329_CR15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00277-009-0875-7","volume":"89","author":"SY Oh","year":"2010","unstructured":"Oh SY, Kim WS, Kim JS, Kim SJ, Kwon HC, Lee DH, et al. Pulmonary marginal zone B-cell lymphoma of MALT type\u2014what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) study. Ann Hematol. 2010;89:563\u20138.","journal-title":"Ann Hematol"},{"key":"3329_CR16","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1002\/cncr.27452","volume":"118","author":"Y Liang","year":"2012","unstructured":"Liang Y, Wang L, Zhu Y, Lin Y, Liu H, Rao H, et al. Primary pulmonary lymphoepithelioma-like carcinoma: fifty-two patients with long-term follow-up. Cancer. 2012;118:4748\u201358.","journal-title":"Cancer"},{"key":"3329_CR17","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1038\/onc.2013.195","volume":"33","author":"S Rosebeck","year":"2014","unstructured":"Rosebeck S, Rehman AO, Apel IJ, Kohrt D, Appert A, O\u2019Donnell MA, et al. The API2-MALT1 fusion exploits TNFR pathway-associated RIP1 ubiquitination to promote oncogenic NF-kappab signaling. Oncogene. 2014;33:2520\u201330.","journal-title":"Oncogene"},{"key":"3329_CR18","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1182\/blood-2010-01-265157","volume":"115","author":"AG Tsai","year":"2010","unstructured":"Tsai AG, Lu Z, Lieber MR. The t(14;18)(q32;q21)\/IGH-MALT1 translocation in MALT lymphomas is a CpG-type translocation, but the t(11;18)(q21;q21)\/API2-MALT1 translocation in MALT lymphomas is not. Blood. 2010;115:3640\u20131. author reply 3641\u20133642.","journal-title":"Blood"},{"key":"3329_CR19","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.humpath.2010.11.022","volume":"42","author":"H Xia","year":"2011","unstructured":"Xia H, Nakayama T, Sakuma H, Yamada S, Sato F, Takino H, et al. Analysis of API2-MALT1 fusion, trisomies, and immunoglobulin VH genes in pulmonary mucosa-associated lymphoid tissue lymphoma. Hum Pathol. 2011;42:1297\u2013304.","journal-title":"Hum Pathol"},{"key":"3329_CR20","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1183\/09031936.00039309","volume":"34","author":"R Borie","year":"2009","unstructured":"Borie R, Wislez M, Thabut G, Antoine M, Rabbat A, Couderc LJ, et al. Clinical characteristics and prognostic factors of pulmonary malt lymphoma. Eur Respir J. 2009;34:1408\u201316.","journal-title":"Eur Respir J"},{"key":"3329_CR21","first-page":"390","volume":"34","author":"AW Li","year":"2012","unstructured":"Li AW, Xu JF, Zhou CC, Wu CY, Wang YL. Clinical characteristics and diagnosis of pulmonary mucosa-associated lymphoid tissue-derived (MALT) lymphoma: a retrospective analysis of 29 cases. Zhonghua Zhong Liu Za Zhi Chin J Oncol. 2012;34:390\u20133.","journal-title":"Zhonghua Zhong Liu Za Zhi Chin J Oncol"},{"key":"3329_CR22","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1200\/JCO.2010.33.4474","volume":"30","author":"P Solal-Celigny","year":"2012","unstructured":"Solal-Celigny P, Bellei M, Marcheselli L, Pesce EA, Pileri S, McLaughlin P, et al. Watchful waiting in low-tumor burden follicular lymphoma in the rituximab era: results of an F2-study database. J Clin Oncol: Off J Am Soc Clin Oncol. 2012;30:3848\u201353.","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"3329_CR23","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/annonc\/mds623","volume":"24","author":"A Wirth","year":"2013","unstructured":"Wirth A, Gospodarowicz M, Aleman BM, Bressel M, Ng A, Chao M, et al. Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-centre, International Extranodal Lymphoma Study Group study. Ann Oncol: Off J Eur Soc Med Oncol ESMO. 2013;24:1344\u201351.","journal-title":"Ann Oncol: Off J Eur Soc Med Oncol ESMO"},{"key":"3329_CR24","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/annonc\/mds644","volume":"24","author":"AJ Olszewski","year":"2013","unstructured":"Olszewski AJ, Castillo JJ. Comparative outcomes of oncologic therapy in gastric extranodal marginal zone (MALT) lymphoma: analysis of the SEER-Medicare database. Ann Oncol: Off J Eur Soc Med Oncol ESMO. 2013;24:1352\u20139.","journal-title":"Ann Oncol: Off J Eur Soc Med Oncol ESMO"},{"key":"3329_CR25","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ijrobp.2013.11.235","volume":"88","author":"K Harada","year":"2014","unstructured":"Harada K, Murakami N, Kitaguchi M, Sekii S, Takahashi K, Yoshio K, et al. Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes. Int J Radiat Oncol Biol Phys. 2014;88:650\u20134.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3329_CR26","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1080\/10428190500137890","volume":"46","author":"EA Chong","year":"2005","unstructured":"Chong EA, Svoboda J, Cherian S, Andreadis C, Downs LH, Zhuang H, et al. Regression of pulmonary MALT lymphoma after treatment with rituximab. Leuk Lymphoma. 2005;46:1383\u20136.","journal-title":"Leuk Lymphoma"},{"key":"3329_CR27","first-page":"169","volume":"66","author":"C Yoshida","year":"2013","unstructured":"Yoshida C, Tarumi S, Kato A, Nii K, Chang SS, Yokomise H. Mucosa-associated lymphoid tissue (MALT) lymphoma of the lung treated by surgery and rituximab; report of a case. Kyobu Geka Jpn J Thorac Surg. 2013;66:169\u201372.","journal-title":"Kyobu Geka Jpn J Thorac Surg"},{"key":"3329_CR28","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1200\/JCO.2011.40.6272","volume":"31","author":"E Zucca","year":"2013","unstructured":"Zucca E, Conconi A, Laszlo D, Lopez-Guillermo A, Bouabdallah R, Coiffier B, et al. Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone b-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study. J Clin Oncol: Off J Am Soc Clin Oncol. 2013;31:565\u201372.","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"3329_CR29","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3324\/haematol.2008.001537","volume":"94","author":"M Troch","year":"2009","unstructured":"Troch M, Jonak C, Mullauer L, Puspok A, Formanek M, Hauff W, et al. A phase II study of bortezomib in patients with MALT lymphoma. Haematologica. 2009;94:738\u201342.","journal-title":"Haematologica"},{"key":"3329_CR30","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/annonc\/mdq416","volume":"22","author":"A Conconi","year":"2011","unstructured":"Conconi A, Martinelli G, Lopez-Guillermo A, Zinzani PL, Ferreri AJ, Rigacci L, et al. Clinical activity of bortezomib in relapsed\/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG). Ann Oncol: Off J Eur Soc Med Oncol ESMO. 2011;22:689\u201395.","journal-title":"Ann Oncol: Off J Eur Soc Med Oncol ESMO"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3329-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-3329-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3329-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T22:51:50Z","timestamp":1598827910000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-3329-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,24]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["3329"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-3329-y","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,24]]}}}